Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is MYCOPHENOLATE SODIUM, with a corresponding US DMF Number 24397.
Remarkably, this DMF maintains an Active status since its submission on November 19, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 15, 2021, and payment made on September 29, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II